Stephen H. Caldwell, Patrick S. C. Leung, James R. Spivey, Thomas Prindiville, Maria de Medina, Theparat Saicheur, Merrill Rowley, K. Rajender Reddy, Ross Coppel, Lennox J. Jeffers, Ian R. MacKay, Eugene R. Schiff, M. Eric Gershwin – 1 October 1992 – The 2‐oxo‐acid dehydrogenase family of enzymes have been identified as the major mitochondrial autoantigens of primary biliary cirrhosis.

Margaret S. Swain, Marcelle Bergeron, Robert Audet, Andres T. Bleiz, Roger F. Butterworth – 1 October 1992 – Alterations of brain and cerebrospinal fluid amino acids have consistently been described in human and experimental fulminant liver failure.

Paul D. Berk – 1 October 1992

Dieter Häussinger – 1 October 1992 – 1 The effects of inhibiting endogenous nitric oxide (NO) synthesis with NG‐monomethyl‐L‐arginine (L‐NMMA) on the systemic and splanchnic circulation have been investigated in rats with experimental chronic portal hypertension, anaesthetized with ketamine.

1 October 1992

I. David Shocket – 1 October 1992

Atsuhiko Machida, Hitoshi Ohnuma, Fumio Tsuda, Eisuke Munekata, Takeshi Tanaka, Yoshihiro Akahane, Hiroaki Okamoto, Shunji Mishiro – 1 October 1992 – Four distinct genotypes of hepatitis C virus types I, II, III and IV have been identified by comparison of nucleotide sequences of isolates from different areas of the world. We examined the possibility that hepatitis C virus may have serologically definable subtypes. Enzyme‐linked immunosorbent assay systems were prepared by use of two synthetic peptides deduced from the putative core protein of hepatitis C virus.

José A. Solis‐Herruzo, Amelia Gonzalez‐Gamarra, Gregorio Castellano, Maria Teresa Muñoz‐yagüe – 1 October 1992 – Metabolic clearance rate and half‐time of arginine vasopressin were measured in 43 cirrhotic patients and 10 control subjects. Synthetic arginine vasopressin was infused intravenously at a rate of 500 pg/min/kg of body weight for 75 min.

Valeer J. Desmet – 1 October 1992

1 October 1992